300+ investors in your industry, stage, and region Get
Any industry
Google
Clean Energy
EdTech
Artificial Intelligence
Local
Enterprise Software
Travel
Platforms
InsurTech
Social Impact
Oil and Gas
Retail
Cryptocurrency
SaaS
Film
Restaurants
Photography
Payments
Email
CleanTech
Energy
Marketplace
Fitness
Organic Food
Machine Learning
Health Care
Agriculture (AgTech)
Gaming
Facebook
Social Network
Blockchain
B2B
Video Games
Big Data
Medical Device
Wellness
Education
Mobile
Automotive
Sports
Legal
eSports
Construction
Hospitality
Biotechnology
Renewable Energy
Consumer
Software
Crowdfunding
Venture Capital
Theatre
Fashion
Medical
Recruiting
Social
Web3
Cannabis
Beauty
LGBT
Celebrity
Infrastructure
Climate
Mobile Apps
Life Science
Music
Wine and Spirits
Food and Beverage
Publishing
Manufacturing
Art
Digital Media
FinTech
Finance
Financial Services
Social Media
Franchise
Mobile Advertising
Non Profit
Real Estate
Internet
Android
Sporting Goods
Sustainability
Hardware
Biotech
Enterprise
Impact
Proptech
Transportation
Community
Media (Entertainment)
Any country
Hong Kong
Thailand
United Arab Emirates
Egypt
Greece
Croatia
South Korea
Singapore
Brazil
Kyrgyzstan
LATAM
Africa
Oceania
Gibraltar
Liberia
Taiwan
Tunisia
Sweden
Zimbabwe
Zambia
Norway
Tajikistan
Mexico
Nigeria
Russian Federation
Togo
Guinea
Nepal
Iran
Isle of Man
Madagascar
Pakistan
Romania
Burkina Faso
Puerto Rico
Oman
Poland
Cameroon
Guernsey
Andorra
Colombia
Sudan
China
Armenia
Costa Rica
Czech Republic
Kuwait
Kenya
Marshall Islands
Luxembourg
Malta
Mozambique
Namibia
Mauritius
Nicaragua
Panama
Serbia
Uzbekistan
New Zealand
Australia
Saudi Arabia
Sri Lanka
Jamaica
Switzerland
Guatemala
Kazakhstan
Cayman Islands
Venezuela
Malawi
Myanmar
Uganda
Turkey
Uruguay
Morocco
Moldova
Seychelles
Botswana
Paraguay
Ireland
Japan
South Africa
France
Georgia
Denmark
Ghana
Canada
Iraq
Mali
Latvia
United Kingdom
Malaysia
Portugal
Philippines
Sierra Leone
Rwanda
El Salvador
Tanzania
Senegal
United States
Germany
India
Middle East
Indonesia
Dominican Republic
Bermuda
Asia
Albania
Argentina
Spain
Angola
Europe
Cyprus
Qatar
Belgium
Barbados
Jordan
Austria
Ethiopia
Azerbaijan
Bulgaria
Ecuador
Bahamas
Faroe Islands
Estonia
Jersey
Bahrain
Bolivia
Algeria
Belize
Finland
Italy
Belarus
Bangladesh
Hungary
Grenada
Israel
Iceland
Cambodia
Honduras
Lithuania
Liechtenstein
Lebanon
Mongolia
Peru
Slovenia
San Marino
Ukraine
Vietnam
Chile
Angel Investors
VC Funds
All Investors
Access Full Database - Free Forever
Open database

Mr. Koenraad Van Loo

CEO & Managing Director @ SFPI-FPIM

Antwerp, Belgium

Mr. Koenraad Van Loo is a seed investor at SFPI-FPIM in Antwerp focused on Health Care and Life Science. Koen Van Loo is the CEO and Managing Director of SFPI-FPIM.

Total investments:
2
Last investment:
Lead investor:
0%

Last updated:

Industries Mr. Koenraad Van Loo invests in

Health CareLife ScienceTherapeuticsBiotechnologySemiconductor

Stages Mr. Koenraad Van Loo invests in

SeedSeries A

Countries Mr. Koenraad Van Loo invests in

Belgium

Investment Focus

Industry

  • Health Care 1 (50%)
  • Life Science 1 (50%)
  • Therapeutics 1 (50%)
  • Biotechnology 1 (50%)
  • Semiconductor 1 (50%)

Stage

  • Seed 1 (50%)
  • Series A 1 (50%)

Investments

CompanyDescriptionRoundLinks
MICLEDI Microdisplays MICLEDI Microdisplays
MICLEDI Microdisplays is an experienced executive in the semiconductor industry, $8.2M / Seed / Apr 03, 2021
ExeVir Bio ExeVir Bio
ExeVir Bio is a Belgium-based company that develops single-domain antibody-based therapies that help patients ward off viral infections. The company is harnessing a llama-derived antibody technology platform to generate robust antiviral therapies providing broad protection against coronaviruses. They using a highly innovative and clinicallyvalidated VHH technology to develop treatments for viral infections that may pose a significant global threat. ExeVir Bio develops a rapid response platform for antivirals. This platform technology enables an agile response to new health threats thanks to its short throughput time to generate drug candidates. The resulting protein-based therapeutics are sufficiently stable and easy to produce at a reasonable cost to enable true global access.ExeVir Bio was founded in 2020 and is headquartered in Zwijnaarde, Belgium. $49.2M / Series A / Jul 28, 2020

Co-Investors

SFPI-FPIM

About SFPI-FPIM

VC Fund · Brussels, Belgium

The Federal Holding and Investment Company (SFPI-FPIM) centrally manages the federal government’s shareholdings, cooperates with the government on specific projects and pursues its own investment policy in the interests of the Belgian economy.

SFPI-FPIM Contacts

NameEmailPhoneSocials
Mr. Johan de Ketelbutter Adviser-General
Mr. Koenraad Van Loo CEO & Managing Director

Sign up to unlock verified contacts

Unlock Contacts

3 more contacts available

Open SFPI-FPIM full profile

Access 48,091 investors

822 industries, 177 countries. Updated daily. Emails and phones included.

Browse database — It's Free!

Find investors for your startup

Search 48,091 investors by industry and country. Emails and phones included.

Any industry
Google
Clean Energy
EdTech
Artificial Intelligence
Local
Enterprise Software
Travel
Platforms
InsurTech
Social Impact
Oil and Gas
Retail
Cryptocurrency
SaaS
Film
Restaurants
Photography
Payments
Email
CleanTech
Energy
Marketplace
Fitness
Organic Food
Machine Learning
Health Care
Agriculture (AgTech)
Gaming
Facebook
Social Network
Blockchain
B2B
Video Games
Big Data
Medical Device
Wellness
Education
Mobile
Automotive
Sports
Legal
eSports
Construction
Hospitality
Biotechnology
Renewable Energy
Consumer
Software
Crowdfunding
Venture Capital
Theatre
Fashion
Medical
Recruiting
Social
Web3
Cannabis
Beauty
LGBT
Celebrity
Infrastructure
Climate
Mobile Apps
Life Science
Music
Wine and Spirits
Food and Beverage
Publishing
Manufacturing
Art
Digital Media
FinTech
Finance
Financial Services
Social Media
Franchise
Mobile Advertising
Non Profit
Real Estate
Internet
Android
Sporting Goods
Sustainability
Hardware
Biotech
Enterprise
Impact
Proptech
Transportation
Community
Media (Entertainment)
Any country
Hong Kong
Thailand
United Arab Emirates
Egypt
Greece
Croatia
South Korea
Singapore
Brazil
Kyrgyzstan
LATAM
Africa
Oceania
Gibraltar
Liberia
Taiwan
Tunisia
Sweden
Zimbabwe
Zambia
Norway
Tajikistan
Mexico
Nigeria
Russian Federation
Togo
Guinea
Nepal
Iran
Isle of Man
Madagascar
Pakistan
Romania
Burkina Faso
Puerto Rico
Oman
Poland
Cameroon
Guernsey
Andorra
Colombia
Sudan
China
Armenia
Costa Rica
Czech Republic
Kuwait
Kenya
Marshall Islands
Luxembourg
Malta
Mozambique
Namibia
Mauritius
Nicaragua
Panama
Serbia
Uzbekistan
New Zealand
Australia
Saudi Arabia
Sri Lanka
Jamaica
Switzerland
Guatemala
Kazakhstan
Cayman Islands
Venezuela
Malawi
Myanmar
Uganda
Turkey
Uruguay
Morocco
Moldova
Seychelles
Botswana
Paraguay
Ireland
Japan
South Africa
France
Georgia
Denmark
Ghana
Canada
Iraq
Mali
Latvia
United Kingdom
Malaysia
Portugal
Philippines
Sierra Leone
Rwanda
El Salvador
Tanzania
Senegal
United States
Germany
India
Middle East
Indonesia
Dominican Republic
Bermuda
Asia
Albania
Argentina
Spain
Angola
Europe
Cyprus
Qatar
Belgium
Barbados
Jordan
Austria
Ethiopia
Azerbaijan
Bulgaria
Ecuador
Bahamas
Faroe Islands
Estonia
Jersey
Bahrain
Bolivia
Algeria
Belize
Finland
Italy
Belarus
Bangladesh
Hungary
Grenada
Israel
Iceland
Cambodia
Honduras
Lithuania
Liechtenstein
Lebanon
Mongolia
Peru
Slovenia
San Marino
Ukraine
Vietnam
Chile
Angel Investors
VC Funds
All Investors

Similar Investors

Recommended lists

FAQ

What does Mr. Koenraad Van Loo invest in?

Mr. Koenraad Van Loo invests primarily in Health Care, Life Science and Therapeutics startups, most often at Seed and Series A stage. Most of the 2 investments tracked by Shizune back companies in Belgium. The Investment Focus section breaks down every industry, stage and country in the portfolio.

When did Mr. Koenraad Van Loo last invest?

The most recent investment recorded for Mr. Koenraad Van Loo closed in Apr 2021. Shizune tracks 2 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.

Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

Contact your first 100 investors today

Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.

Find investors — It's Free!
Mr. Koenraad Van Loo Find email